NCT ID | NCT02041481 |
Title | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | no |
Sponsors | City of Hope Medical Center, National Cancer Institute (NCI), Novartis |
Indications | |
Therapies | |
Age Groups: | adult |